Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023

Dita C. Bolluyt; Sjoerd M. Euser; Dennis Souverein; Annemarie Mc van Rossum; Jayant Kalpoe; Mireille van Westreenen; Marco Goeijenbier; Dominic Snijders; Dirk Eggink; Femke Jongenotter; Steven Fl van Lelyveld; Marlies A. van Houten

doi:10.2807/1560-7917.ES.2024.29.4.2300724

Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023

Dita C. Bolluyt
, Sjoerd M. Euser
, Dennis Souverein
, Annemarie Mc van Rossum
, Jayant Kalpoe
, Mireille van Westreenen
, Marco Goeijenbier
, Dominic Snijders
, Dirk Eggink
, Femke Jongenotter
, Steven Fl van Lelyveld^*
, Marlies A. van Houten

^*Corresponding author for this work

Spaarne Gasthuis
Regional Public Health Laboratory Kennemerland
National Institute of Public Health and the Environment

Research output: Contribution to journal › Article › Academic › peer-review

39 Citations (Scopus)

67 Downloads (Pure)

Abstract

Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especially children.

Original language	English
Journal	Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Volume	29
Issue number	4
DOIs	https://doi.org/10.2807/1560-7917.ES.2024.29.4.2300724
Publication status	Published - 25 Jan 2024

Bibliographical note

Publisher Copyright:
© The Author(s), 2024.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2807/1560-7917.ES.2024.29.4.2300724Licence: CC BY

Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023Final published version, 233 KBLicence: CC BY

Cite this

Bolluyt, D. C., Euser, S. M., Souverein, D., van Rossum, A. M., Kalpoe, J., van Westreenen, M., Goeijenbier, M., Snijders, D., Eggink, D., Jongenotter, F., van Lelyveld, S. F., & van Houten, M. A. (2024). Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 29(4). https://doi.org/10.2807/1560-7917.ES.2024.29.4.2300724

@article{7052f53d3d5e4b25b7d82732a1e05e99,

title = "Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023",

abstract = "Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especially children.",

author = "Bolluyt, \{Dita C.\} and Euser, \{Sjoerd M.\} and Dennis Souverein and \{van Rossum\}, \{Annemarie Mc\} and Jayant Kalpoe and \{van Westreenen\}, Mireille and Marco Goeijenbier and Dominic Snijders and Dirk Eggink and Femke Jongenotter and \{van Lelyveld\}, \{Steven Fl\} and \{van Houten\}, \{Marlies A.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s), 2024.",

year = "2024",

month = jan,

day = "25",

doi = "10.2807/1560-7917.ES.2024.29.4.2300724",

language = "English",

volume = "29",

journal = "Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin",

issn = "1560-7917",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "4",

}

Bolluyt, DC, Euser, SM, Souverein, D, van Rossum, AM, Kalpoe, J, van Westreenen, M , Goeijenbier, M, Snijders, D, Eggink, D, Jongenotter, F, van Lelyveld, SF & van Houten, MA 2024, 'Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023', Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, vol. 29, no. 4. https://doi.org/10.2807/1560-7917.ES.2024.29.4.2300724

Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023. / Bolluyt, Dita C.; Euser, Sjoerd M.; Souverein, Dennis et al.
In: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 29, No. 4, 25.01.2024.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023

AU - Bolluyt, Dita C.

AU - Euser, Sjoerd M.

AU - Souverein, Dennis

AU - van Rossum, Annemarie Mc

AU - Kalpoe, Jayant

AU - van Westreenen, Mireille

AU - Goeijenbier, Marco

AU - Snijders, Dominic

AU - Eggink, Dirk

AU - Jongenotter, Femke

AU - van Lelyveld, Steven Fl

AU - van Houten, Marlies A.

PY - 2024/1/25

Y1 - 2024/1/25

N2 - Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especially children.

AB - Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especially children.

UR - https://www.scopus.com/pages/publications/85183507644

U2 - 10.2807/1560-7917.ES.2024.29.4.2300724

DO - 10.2807/1560-7917.ES.2024.29.4.2300724

M3 - Article

C2 - 38275014

AN - SCOPUS:85183507644

SN - 1560-7917

VL - 29

JO - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

JF - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

IS - 4

ER -

Bolluyt DC, Euser SM, Souverein D, van Rossum AM, Kalpoe J, van Westreenen M et al. Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2024 Jan 25;29(4). doi: 10.2807/1560-7917.ES.2024.29.4.2300724

Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this